CSI Market
Sign In | Register

Revolution Medicines Inc (RVMD) Annual Balance Sheets

Annual · GAAP · USD millions
Access RVMD quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Revolution Medicines Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent383.75
Marketable Securities, Current SH1,641.93
Cash & Short-term Investments2,024.00
Accounts receivable0.00
Prepaid Expense And Other Assets Current49.36
Total Current Assets2,075.04
Equipment/Property/Plant Net33.19
Goodwill net14.61
Intangible Assets55.80
Deposits Assets, Noncurrent AS24.15
Other Assets, Noncurrent151.72
Operating Lease Right Of Use Asset132.08
Restricted Cash Noncurrent4.86
Total Assets2,354.51
Liabilities
Accounts Payable, Current AC64.62
Accrued Royalties268.45
Other Liabilities, Current0.00
Total Current Liabilities333.06
Total Long-term Debt0.00
Other liabilities, Noncurrent390.15
Accrued Expenses And Other Current Liabilities209.34
Operating Lease Liability Current16.47
Warrant Liability18.55
Deferred Income Tax Liabilities Net2.35
Operating Lease Liability Noncurrent142.23
Total Liabilities723.21
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock4,497.14
Retained Earnings / Accumulated Deficit-2,869.10
Other Equity3.24
Common Stockholder's Equity1,631.30
Total Stockholder's Equity1,631.30
Liabilities & Stockholder's Equity2,354.51
4 historic quarters locked

Sign in to unlock the full Revolution Medicines Inc balance sheet history.

Sign In Create Free Account

About Revolution Medicines Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: rvmd-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-071563

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License